IP Library Granted Patent US 7,771,956
Granted Patent B2
US 7,771,956 · App. 10/562,269 · Granted Aug 10, 2010

Method for detecting the presence of a phospholipid

Assignees: Brigham & Women's Hospital, Inc.; United States of America Department of Veterans Affairs
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,771,956
App. No.
10/562,269
Granted
Aug 10, 2010
Kind
B2
Abstract

A method, kit and probe for detecting the presence of a phospholipid, such as phosphatidylserine, in a biological material is provided. A binding agent including lactadherin, a fragment of lactadherin, a functional equivalent of lactadherin, or a functional equivalent of a fragment of lactadherin, is used to detect the presence of any phospholipid.

Claims (19)

1. A method of detecting the presence of a phospholipid in a biological material, comprising the steps of:

a) providing a biological material;

b) contacting the biological material with at least one binding agent selected from the group consisting of lactadherin, a fragment of lactadherin, a functional equivalent of lactadherin, and a functional equivalent of a fragment of lactadherin;

c) binding the biological material and the binding agent; and

d) detecting the presence of any phospholipid bound to the binding agent or the binding agent bound to the biological material.

2. The method of claim 1 , wherein:

the phospholipid comprises phosphatidylserine.

3. The method of claim 1 , wherein:

the phospholipid comprises a phospho-L-serine moiety of phosphatidylserine.

4. The method of claim 2 , wherein:

the biological material comprises a cell, a cell membrane, a cell appendage, a cell fragment, a lipoprotein, or a cellular particle.

5. The method of claim 4 , wherein:

any binding in step c) is independent of any Ca ++ or phosphatidylethanolamine.

6. The method of claim 4 , wherein:

any binding in step c) is increased with increasing of cell membrane curvature.

7. The method of claim 2 , wherein:

any binding in step c) increases proportionally to the content of phosphatidylserine in a range of about 0-2%.

8. The method of claim 4 , wherein:

the cell membrane comprises a curved region.

Assignments (4)
CONFIRMATORY LICENSE Recorded Aug 8, 2010
From: BRIGHAM AND WOMEN'S HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024805/0541 →
CONFIRMATORY LICENSE Recorded Jun 12, 2009
From: BRIGHAM AND WOMEN'S HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022817/0114 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2007
From: GILBERT, GARY E.; SHI, JIALAN, MD, PH.D.
To: BRIGHAM & WOMEN'S HOSTPITAL, INC., THE; U.S. DEPARTMENT OF VETERANS AFFAIRS
Reel/Frame 019596/0865 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2005
From: GILBERT, GARY E.; SHI, JIALAN
To: BRIGHAM & WOMEN'S HOSPITAL, INC., THE; U.S. DEPARTMENT OF VETERANS AFFAIRS
Reel/Frame 017425/0042 →
Continuity (2)
Provisional Application 6048312100 · Jun 30, 2003
Related Publication 20070249734A1 · Oct 25, 2007